Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
JCO Precision Oncology
|
July 9, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology
|
February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 27, 2023
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Current Problems in Surgery
|
March 19, 2008
Recent advances in thyroid cancer. In brief
Elizabeth G Grubbs, Thereasa A Rich, Guojun Li, et al.
Current Problems in Surgery
|
March 19, 2008
Recent advances in thyroid cancer
Elizabeth G Grubbs, Thereasa A Rich, Guojun Li, et al.
Cancer Discovery
|
April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
Vivek Subbiah, Justin F Gainor, Rami Rahal, et al.
The Lancet. Diabetes & Endocrinology
|
June 12, 2021
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
Vivek Subbiah, Mimi I Hu, Lori J Wirth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues
Sarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Head & Neck
|
May 22, 2020
Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines
Yelda Jozaghi, Mark E Zafereo, Nancy D Perrier, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
JCO Precision Oncology
|
July 9, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology
|
February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 27, 2023
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study
Vivek Subbiah, Mimi I Hu, Aaron S Mansfield, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Current Problems in Surgery
|
March 19, 2008
Recent advances in thyroid cancer. In brief
Elizabeth G Grubbs, Thereasa A Rich, Guojun Li, et al.
Current Problems in Surgery
|
March 19, 2008
Recent advances in thyroid cancer
Elizabeth G Grubbs, Thereasa A Rich, Guojun Li, et al.
Cancer Discovery
|
April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
Vivek Subbiah, Justin F Gainor, Rami Rahal, et al.
The Lancet. Diabetes & Endocrinology
|
June 12, 2021
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
Vivek Subbiah, Mimi I Hu, Lori J Wirth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues
Sarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Head & Neck
|
May 22, 2020
Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines
Yelda Jozaghi, Mark E Zafereo, Nancy D Perrier, et al.
Page
of 10